EPIDYOLEX
Live / Applied — New application — not yet assigned to an examiner (as of 10 Mar 2026)
What this means for you
Not registered yet, but its 10 Mar 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99694076
- Mark type
- Stylized text
- Filed
- 10 Mar 2026
- Attorney of record
- Michael T. Olsen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations and substances in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for use in the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; pharmaceutical preparations and substances in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; medicinal infusions in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for use in the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome
Owner
- Jazz Pharmaceuticals Research UK Limited, Sittingbourne, GB
Prior registrations
Prosecution history
- 10 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 10 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 10 Mar 2026 — NEW APPLICATION ENTERED